Diya Surie
Centers for Disease Control and Prevention(US)National Center for Immunization and Respiratory Diseases(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, COVID-19 Clinical Research Studies, Influenza Virus Research Studies, Pneumonia and Respiratory Infections
Most-Cited Works
- → Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19(2026)3 cited
- → Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022–September 2023(2025)1 cited
- → Genomic surveillance of human metapneumovirus in the United States, 2010 – 2025(2026)
- → P-1487. Respiratory syncytial virus (RSV) vaccination in adults aged <60 years at increased risk of severe RSV disease: considerations of the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices(2026)
- → Effectiveness of COVID-19 Vaccines by Genetic Match to Circulating SARS-CoV-2 Strains in the United States, 2023–2025(2026)
- → Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness—IVY network, January 24, 2022–September 1, 2024(2026)
- → Integrating Genomic Data into Test-negative Designs for Estimating Lineage-specific COVID-19 Vaccine Effectiveness(2026)
- → 181. RSV Vaccine Effectiveness Against RSV-Associated Hospitalization Among US Adults Aged 60 Years and Older Over Two RSV Seasons(2026)